Completed
There is strong interest across many stakeholders to increase progress around developing treatments for dry age-related macular degeneration (AMD). Advancements in drug discovery and development in dry AMD have been limited and slow due to issues surrounding disease characterization, surrogate endpoints, and clinical trial design. Given the pressing need for progress in the field, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop on November 15, 2014, bringing together key stakeholders, to discuss opportunities for advancing drug development for dry AMD, specifically geographic atrophy.
Featured publication
Workshop_in_brief
ยท2015
Age-related macular degeneration (AMD) is the leading cause of blindness among white Americans and others of European descent, with lower prevalence among those of Asian, Latino, or African ancestry. The overall prevalence of AMD is approximately 8.7 percent worldwide and is expected to rise to 196...
View details
Description
An ad hoc committee will plan and host a one-day public workshop that will explore the science necessary to overcome current challenges associated with drug discovery and development to support dry age-related macular degeneration (AMD). Specifically, presentations and discussions will be designed to help participants:
- Consider scientific opportunities and challenges in identifying and validating potential new targets for intervention;
- Discuss opportunities to improve current and develop new animal models for dry AMD; and
- Consider the evidence needed to use potential biomarkers as surrogate end points in clinical trials, and how to generate that evidence.
The committee will develop the agenda for the workshop session, select and invite speakers and discussants, and moderate the discussions. An individually authored brief workshop summary based on the presentations and discussions held during the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Committee
Matthew McMahon
Co-Chair
David Michelson
Co-Chair
Anthony Adamis
Member
Daniel J. Burch
Member
Wen Chen
Member
Judith Delgado
Member
David Eveleth
Member
Cynthia Owsley
Member
Stephen M. Rose
Member
Philip J. Rosenfeld
Member
Rhett Schiffman
Member
Michael R. Schwartz
Member
Janet Sunness
Member
Sponsors
Department of Health and Human Services
National Science Foundation
Other, Federal
Private: For Profit
Private: Non Profit
Staff
Diana Pankevich
Lead
Clare Stroud
Lead
Sheena Posey Norris
Major units and sub-units
Institute of Medicine
Lead
Board on Health Sciences Policy
Lead